190 related articles for article (PubMed ID: 11144670)
1. Genetics of energetics: transcriptional responses in cardiac metabolism.
Taegtmeyer H
Ann Biomed Eng; 2000 Aug; 28(8):871-6. PubMed ID: 11144670
[TBL] [Abstract][Full Text] [Related]
2. Metabolic reprogramming via PPARα signaling in cardiac hypertrophy and failure: From metabolomics to epigenetics.
Warren JS; Oka SI; Zablocki D; Sadoshima J
Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H584-H596. PubMed ID: 28646024
[TBL] [Abstract][Full Text] [Related]
3. Glucose is preferentially utilized for biomass synthesis in pressure-overloaded hearts: evidence from fatty acid-binding protein-4 and -5 knockout mice.
Umbarawan Y; Syamsunarno MRAA; Koitabashi N; Yamaguchi A; Hanaoka H; Hishiki T; Nagahata-Naito Y; Obinata H; Sano M; Sunaga H; Matsui H; Tsushima Y; Suematsu M; Kurabayashi M; Iso T
Cardiovasc Res; 2018 Jul; 114(8):1132-1144. PubMed ID: 29554241
[TBL] [Abstract][Full Text] [Related]
4. Perturbations in the gene regulatory pathways controlling mitochondrial energy production in the failing heart.
Aubert G; Vega RB; Kelly DP
Biochim Biophys Acta; 2013 Apr; 1833(4):840-7. PubMed ID: 22964268
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of metabolic processes: implications for cardiac metabolism.
van Bilsen M; van der Vusse GJ; Reneman RS
Pflugers Arch; 1998 Dec; 437(1):2-14. PubMed ID: 9817779
[TBL] [Abstract][Full Text] [Related]
6. Metabolic remodelling of the failing heart: beneficial or detrimental?
van Bilsen M; van Nieuwenhoven FA; van der Vusse GJ
Cardiovasc Res; 2009 Feb; 81(3):420-8. PubMed ID: 18854380
[TBL] [Abstract][Full Text] [Related]
7. Hearts lacking caveolin-1 develop hypertrophy with normal cardiac substrate metabolism.
Augustus AS; Buchanan J; Gutman E; Rengo G; Pestell RG; Fortina P; Koch WJ; Bensadoun A; Abel ED; Lisanti MP
Cell Cycle; 2008 Aug; 7(16):2509-18. PubMed ID: 18719368
[TBL] [Abstract][Full Text] [Related]
8. Metabolic therapy at the crossroad: how to optimize myocardial substrate utilization?
Kolwicz SC; Tian R
Trends Cardiovasc Med; 2009 Aug; 19(6):201-7. PubMed ID: 20211436
[TBL] [Abstract][Full Text] [Related]
9. Energy metabolism in heart failure and remodelling.
Ingwall JS
Cardiovasc Res; 2009 Feb; 81(3):412-9. PubMed ID: 18987051
[TBL] [Abstract][Full Text] [Related]
10. Deranged energy substrate metabolism in the failing heart.
Tian Q; Barger PM
Curr Hypertens Rep; 2006 Dec; 8(6):465-71. PubMed ID: 17087857
[TBL] [Abstract][Full Text] [Related]
11. Metabolic impairment in response to early induction of C/EBPβ leads to compromised cardiac function during pathological hypertrophy.
Banerjee D; Datta Chaudhuri R; Niyogi S; Roy Chowdhuri S; Poddar Sarkar M; Chatterjee R; Chakrabarti P; Sarkar S
J Mol Cell Cardiol; 2020 Feb; 139():148-163. PubMed ID: 31958467
[TBL] [Abstract][Full Text] [Related]
12. Nuclear receptor signaling and cardiac energetics.
Huss JM; Kelly DP
Circ Res; 2004 Sep; 95(6):568-78. PubMed ID: 15375023
[TBL] [Abstract][Full Text] [Related]
13. Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?
van Bilsen M; Smeets PJ; Gilde AJ; van der Vusse GJ
Cardiovasc Res; 2004 Feb; 61(2):218-26. PubMed ID: 14736538
[TBL] [Abstract][Full Text] [Related]
14. Metabolic energetics and genetics in the heart.
Taegtmeyer H; Wilson CR; Razeghi P; Sharma S
Ann N Y Acad Sci; 2005 Jun; 1047():208-18. PubMed ID: 16093498
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Coordination of Physiological and Pathological Cardiac Remodeling.
Gibb AA; Hill BG
Circ Res; 2018 Jun; 123(1):107-128. PubMed ID: 29929976
[TBL] [Abstract][Full Text] [Related]
16. Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes.
Kolwicz SC; Purohit S; Tian R
Circ Res; 2013 Aug; 113(5):603-16. PubMed ID: 23948585
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial proteins in hypertrophy and atrophy: a transcript analysis in rat heart.
Taegtmeyer H; Razeghi P; Young ME
Clin Exp Pharmacol Physiol; 2002 Apr; 29(4):346-50. PubMed ID: 11985548
[TBL] [Abstract][Full Text] [Related]
18. Heart spotting.
el Azzouzi H; De Windt LJ
Basic Res Cardiol; 2008 May; 103(3):228-31. PubMed ID: 18274799
[TBL] [Abstract][Full Text] [Related]
19. Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart.
Jaswal JS; Keung W; Wang W; Ussher JR; Lopaschuk GD
Biochim Biophys Acta; 2011 Jul; 1813(7):1333-50. PubMed ID: 21256164
[TBL] [Abstract][Full Text] [Related]
20. Metabolic remodeling in hypertrophied and failing myocardium: a review.
Peterzan MA; Lygate CA; Neubauer S; Rider OJ
Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H597-H616. PubMed ID: 28646030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
